Reimbursed Care Access in Mozambique

Currently classified as a strictly controlled substance under Mozambique's drug control framework with no authorized medical use outside of approved clinical research. Claims about scheduling and absence of routine medical access follow the national drug law regime that implements international conventions, which governs substances listed in the annexed schedules. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Mozambique's Law No. 3/97 establishes control over psychotropic substances and the Ministry of Health and other authorities regulate authorizations for any medical or research uses. #

Esketamine (marketed as SPRAVATO® in some jurisdictions) does not appear to have publicly listed treatment centers or a marketed reimbursement program in Mozambique; Janssen's international treatment-center locator indicates no publicly available treatment center listing outside the United States and countries with established programs, and there is no evidence of national registration or public reimbursement for esketamine in Mozambique. Therefore esketamine is not available as a reimbursed product in routine care and would only be accessible via exceptional importation or participation in an authorized clinical trial if such a trial were approved locally. # #

Ketamine is an established, registered anesthetic and analgesic agent used within Mozambican hospitals and emergency services and is listed on international essential-medicine lists; its medical use for anesthesia and analgesia is regulated by the Ministry of Health under the national drug-control framework. Ketamine is available for routine medical purposes (surgery, trauma care, obstetric anesthesia) and is controlled in distribution and prescription—its clinical use is within the formal health system and procurement is typically through Ministry of Health/public hospital supply chains or private-sector suppliers. Seizure reports and law enforcement actions indicate ketamine is a controlled substance in Mozambique subject to monitoring and anti-trafficking measures. # # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Mozambique's drug-control instruments implement international psychotropics scheduling and provide no routine medical or reimbursed access for DMT. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no public evidence of licensed medical programs, registration, or reimbursement for 5‑MeO‑DMT in Mozambique. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no indication of regulated, reimbursed ibogaine programs or sanctioned clinics operating under health-authority approval in Mozambique. #

Ayahuasca as a sacramental plant brew occupies a complex category: plant-based traditional medicines themselves are not specifically listed in many schedules, but the principal active compound (DMT) is controlled. Practically, Mozambique's drug law regulates substances and their preparations through schedules and implementing decrees, meaning that any brew containing scheduled psychotropic constituents (DMT) would be controlled; there is no recognized, reimbursed medical program for ayahuasca. Where traditional use occurs informally it may not be actively prosecuted, but legally the controlled-psychoactive constituents remain regulated. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Possession, production, or distribution of mescaline or mescaline-containing cacti preparations would fall under the controlled-substance regime established by Mozambican law. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Novel phenethylamine psychedelics (the 2C series) are captured by the country's scheduling approach and illicit‑trafficking provisions; there is no authorized medical or reimbursed access. #